Genmab A/S

ISIN DK0010272202

WKN 565131

Market cap (in EUR)

18,758 m

Country

Denmark

Sector

Healthcare

Dividend yield

0.00%

Overview

Quote

Description

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.

Show more Show less

Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals Denmark

Chart

Financials

Key metrics

Market capitalisation, EUR	18,758 m
EPS, EUR	21.42
P/B ratio	3.7
P/E ratio	13.6
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	2,887 m
Net income, EUR	1,052 m
Profit margin	36.44%

What ETF is Genmab A/S in?

There are 50 ETFs which contain Genmab A/S. All of these ETFs are listed in the table below. The ETF with the largest weighting of Genmab A/S is the Xtrackers MSCI Nordic UCITS ETF 1D.

ETF	Weight	Investment focus	Fund size (in m EUR)
UBS Core MSCI World UCITS ETF USD acc	0.03%	Equity World	5,939
iShares MSCI World UCITS ETF (Dist)	0.03%	Equity World	7,513
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating	0.03%	Equity World Multi-Asset Strategy	896
VanEck Multi-Asset Conservative Allocation UCITS ETF	0.19%	Equity World Social/Environmental Multi-Asset Strategy	20
Vanguard FTSE All-World UCITS ETF (USD) Accumulating	0.02%	Equity World	27,971
UBS MSCI World Socially Responsible UCITS ETF USD dis	0.11%	Equity World Social/Environmental Climate Change	4,023
UBS Core MSCI World UCITS ETF USD dis	0.03%	Equity World	1,334
Vanguard FTSE Developed World UCITS ETF Acc	0.02%	Equity World	4,903
UBS Core MSCI World UCITS ETF hGBP dis	0.03%	Equity World	94
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing	0.01%	Equity World Multi-Asset Strategy	34
iShares MSCI ACWI UCITS ETF USD (Acc)	0.02%	Equity World	22,108
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing	0.03%	Equity World Multi-Asset Strategy	67
iShares STOXX Europe 600 Health Care UCITS ETF (DE)	1.06%	Equity Europe Health Care	760
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.02%	Equity World Social/Environmental	497
HSBC EUROPE EX UK SCREENED EQUITY UCITS ETF EUR (Dist)	0.33%	Equity Europe Social/Environmental Climate Change	63
UBS Core MSCI World UCITS ETF hEUR acc	0.03%	Equity World	308
Vanguard FTSE Developed Europe ex UK UCITS ETF (EUR) Distributing	0.19%	Equity Europe	3,329
iShares MSCI Europe Paris-Aligned Climate UCITS ETF EUR (Dist)	0.10%	Equity Europe Social/Environmental Climate Change	28
Vanguard FTSE Developed World UCITS ETF Distributing	0.02%	Equity World	3,563
Amundi MSCI Europe UCITS ETF Acc	0.16%	Equity Europe	583
iShares MSCI Europe ex-UK UCITS ETF	0.19%	Equity Europe	1,289
iShares MSCI World SRI UCITS ETF USD (Dist)	0.10%	Equity World Social/Environmental	1,485
Amundi MSCI Europe SRI Climate Paris Aligned UCITS ETF DR (D)	0.84%	Equity Europe Social/Environmental	87
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating	0.01%	Equity World Multi-Asset Strategy	87
iShares MSCI Europe SRI UCITS ETF EUR (Dist)	0.66%	Equity Europe Social/Environmental	224
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist)	0.59%	Equity World Health Care Social/Environmental	530
Xtrackers MSCI Europe UCITS ETF 1D	0.15%	Equity Europe	135
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing	0.01%	Equity World Multi-Asset Strategy	14
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating	0.02%	Equity World Multi-Asset Strategy	683
Xtrackers MSCI World UCITS ETF 1D	0.02%	Equity World	4,574
iShares Edge MSCI Europe Minimum Volatility UCITS ETF EUR (Dist)	0.27%	Equity Europe Low Volatility/Risk Weighted	23
Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing	0.19%	Equity Europe Social/Environmental	33
iShares Edge MSCI Europe Quality Factor UCITS ETF EUR (Dist)	0.20%	Equity Europe Fundamental/Quality	30
iShares MSCI World Screened UCITS ETF USD (Dist)	0.03%	Equity World Social/Environmental	965
iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)	0.01%	Equity World Social/Environmental Climate Change	135
Amundi Core MSCI Europe UCITS ETF Dist	0.15%	Equity Europe	518
Vanguard FTSE Developed Europe UCITS ETF (EUR) Accumulating	0.14%	Equity Europe	2,143
Vanguard FTSE All-World UCITS ETF (USD) Distributing	0.02%	Equity World	19,168
iShares MSCI Europe Screened UCITS ETF EUR (Dist)	0.17%	Equity Europe Social/Environmental	466
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating	0.01%	Equity World Multi-Asset Strategy	193
iShares Core MSCI Europe UCITS ETF EUR (Dist)	0.15%	Equity Europe	10,749
Amundi Prime Europe UCITS ETF DR (D)	0.16%	Equity Europe	205
iShares MSCI Europe ESG Enhanced CTB UCITS ETF EUR (Dist)	0.04%	Equity Europe Social/Environmental	4,270
Amundi MSCI Europe Growth UCITS ETF Dist	0.31%	Equity Europe Growth	73
Vanguard FTSE Developed Europe UCITS ETF Distributing	0.14%	Equity Europe	4,326
iShares MSCI World ESG Enhanced CTB UCITS ETF USD (Dist)	0.01%	Equity World Social/Environmental	987
Xtrackers MSCI Nordic UCITS ETF 1D	1.35%	Equity Europe	932
Vanguard FTSE Developed Europe ex UK UCITS ETF (EUR) Accumulating	0.19%	Equity Europe	1,129
iShares MSCI Europe SRI UCITS ETF EUR Hedged (Dist)	0.66%	Equity Europe Social/Environmental	10
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing	0.02%	Equity World Multi-Asset Strategy	89

Performance

Returns overview

YTD	+6.08%
1 month	+8.34%
3 months	+6.35%
6 months	+57.63%
1 year	+34.22%
3 years	-21.40%
5 years	-14.48%
Since inception (MAX)	+92.78%
2025	+35.95%
2024	-30.38%
2023	-27.16%
2022	+12.59%

Monthly returns in a heat map

Risk

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF returns include dividend payments (if applicable).